iSpecimen (ISPC) Stock Forecast for 2024–2028. Sell or Buy Prediction
All stock predictions
All currency forecasts
All cryptocurrency predictions

This Month Predictions for ISPC stock
iSpecimen Inc. Analysis
ISPC Stock News


Popular stocks:
Suncor Energy
Amazon
Energy Transfer
Square
Etsy
Micron

TOP Stocks:
Microsoft
Apple
Tesla
Alibaba
Amazon
American Airlines
NVIDIA
Adobe

Shares of other companies:
Udemy
Perion Network
Energy Transfer
Tapestry
McDonald's
NetEase
Jupiter Wellness
indie Semiconductor
Locafy
Bitfarms


Financial News

Popular Stocks Analysis

Helpful Highlights
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

Human error is common in forex trading and often leads to familiar trading issues. These trading mishaps lead to significant novice traders regularly. …
  1. Home
    2. »
  2. Stock forecasts
    3. »
  3. ISPC

iSpecimen (ISPC) Stock Forecast for 2024–2028. Sell or Buy?

Updated: April 19, 2024 (17:54)

Sector: Healthcare

The share price of iSpecimen Inc. (ISPC) now

Latest session on the 19th of April for
iSpecimen Inc. is negative
Trading Volume: 2826471
Open: 0.36 /  High: 0.36 /  Low: 0.276
What analysts predict: $3
52-week High/Low: $2.046 / $0.2

50/200 Day Moving Average: $0.368 / $0.684

This figure corresponds to the Average Price over the previous 50/200 days. For iSpecimen stocks, the 50-day moving average is the support level today.

For iSpecimen stocks, the 200-day moving average is the resistance level today.

Are you interested in iSpecimen Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the iSpecimen stock price in 2024, 2025, 2026, 2027, 2028. How much will one iSpecimen share be worth in 2024 - 2028?

When should I take profit in iSpecimen stock? When should I record a loss on iSpecimen stock? What are analysts' forecasts for iSpecimen stock? What is the future of iSpecimen stock? We forecast iSpecimen stock performance using neural networks based on historical data on iSpecimen stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

iSpecimen stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for iSpecimen shares. This happens once a day.


Historical and forecast chart of iSpecimen stock

The chart below shows the historical price of iSpecimen stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the iSpecimen stock price can be found in the table below.

Long-term forecasts by years.

iSpecimen, Inc. operates as healthcare organization that engages in procurement of human biospecimens. It collects biofluids, human tissue, hematopoietic stem, and immune cells. The company was founded by Christopher Ianelli in July 2009 and is headquartered in Lexington, MA.

iSpecimen daily forecast for a month

Date Target Pes. Opt. Vol., %
Apr 21 0.42 0.41 0.42 2.54
Apr 22 0.41 0.41 0.43 5.06
Apr 23 0.40 0.39 0.41 5.25
Apr 24 0.40 0.39 0.41 5.22
Apr 25 0.42 0.41 0.43 5.21
Apr 26 0.43 0.43 0.44 4.14
Apr 27 0.43 0.42 0.43 2.27
Apr 28 0.43 0.42 0.43 3.09
Apr 29 0.44 0.42 0.45 6.15
Apr 30 0.44 0.43 0.45 3.84
May 01 0.42 0.42 0.43 3.90
May 02 0.43 0.42 0.44 3.21
May 03 0.45 0.44 0.46 5.35
May 04 0.47 0.46 0.48 5.03
May 05 0.48 0.47 0.49 4.88
May 06 0.50 0.49 0.51 2.43
May 07 0.49 0.48 0.51 6.25
May 08 0.49 0.48 0.50 5.50
May 09 0.46 0.46 0.47 2.23
May 10 0.45 0.43 0.46 7.43
May 11 0.44 0.44 0.45 2.49
May 12 0.43 0.42 0.44 5.30
May 13 0.43 0.42 0.45 5.89
May 14 0.45 0.44 0.46 5.50
May 15 0.46 0.45 0.48 7.39
May 16 0.46 0.45 0.48 4.65
May 17 0.47 0.46 0.47 2.90
May 18 0.45 0.44 0.46 4.76
May 19 0.44 0.43 0.46 6.74
May 20 0.45 0.45 0.46 2.53

iSpecimen Daily Price Targets


iSpecimen Stock Forecast 04-21-2024.

Forecast target price for 04-21-2024: $0.42.
Negative dynamics for iSpecimen shares will prevail with possible volatility of 2.473%.
Pessimistic target level: 0.41
Optimistic target level: 0.42

iSpecimen Stock Forecast 04-22-2024.

Forecast target price for 04-22-2024: $0.41.
Negative dynamics for iSpecimen shares will prevail with possible volatility of 4.815%.
Pessimistic target level: 0.41
Optimistic target level: 0.43

iSpecimen Stock Forecast 04-23-2024.

Forecast target price for 04-23-2024: $0.40.
Negative dynamics for iSpecimen shares will prevail with possible volatility of 4.993%.
Pessimistic target level: 0.39
Optimistic target level: 0.41

iSpecimen Stock Forecast 04-24-2024.

Forecast target price for 04-24-2024: $0.40.
Positive dynamics for iSpecimen shares will prevail with possible volatility of 4.958%.
Pessimistic target level: 0.39
Optimistic target level: 0.41

iSpecimen Stock Forecast 04-25-2024.

Forecast target price for 04-25-2024: $0.42.
Positive dynamics for iSpecimen shares will prevail with possible volatility of 4.954%.
Pessimistic target level: 0.41
Optimistic target level: 0.43

iSpecimen Stock Forecast 04-26-2024.

Forecast target price for 04-26-2024: $0.43.
Positive dynamics for iSpecimen shares will prevail with possible volatility of 3.977%.
Pessimistic target level: 0.43
Optimistic target level: 0.44

ISPC (ISPC) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
May. 0.23 0.22 0.25 11.74
Jun. 0.25 0.23 0.28 17.48
Jul. 0.24 0.23 0.27 15.53
Aug. 0.25 0.22 0.27 16.89
Sep. 0.24 0.21 0.27 21.43
Oct. 0.23 0.22 0.24 10.28
Nov. 0.26 0.23 0.27 14.93
Dec. 0.24 0.23 0.26 9.74
Full forecast for 2024

iSpecimen forecast for this year


iSpecimen Stock Prediction for May 2024

An downtrend is forecast for this month with an optimal target price of $0.231086. Pessimistic: $0.22. Optimistic: $0.25


iSpecimen Stock Prediction for Jun 2024

An uptrend is forecast for this month with an optimal target price of $0.250497. Pessimistic: $0.23. Optimistic: $0.28


iSpecimen Stock Prediction for Jul 2024

An downtrend is forecast for this month with an optimal target price of $0.242982. Pessimistic: $0.23. Optimistic: $0.27


iSpecimen Stock Prediction for Aug 2024

An uptrend is forecast for this month with an optimal target price of $0.249178. Pessimistic: $0.22. Optimistic: $0.27


iSpecimen Stock Prediction for Sep 2024

An downtrend is forecast for this month with an optimal target price of $0.240582. Pessimistic: $0.21. Optimistic: $0.27


iSpecimen Stock Prediction for Oct 2024

An downtrend is forecast for this month with an optimal target price of $0.226869. Pessimistic: $0.22. Optimistic: $0.24


iSpecimen Stock Prediction for Nov 2024

An uptrend is forecast for this month with an optimal target price of $0.259538. Pessimistic: $0.23. Optimistic: $0.27


iSpecimen Stock Prediction for Dec 2024

An downtrend is forecast for this month with an optimal target price of $0.24163. Pessimistic: $0.23. Optimistic: $0.26



iSpecimen (ISPC) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 0.26 0.24 0.27 10.03
Feb 0.26 0.23 0.27 15.40
Mar 0.26 0.24 0.29 15.08
Apr 0.27 0.25 0.29 15.95
May 0.28 0.26 0.30 11.18
Jun 0.28 0.27 0.30 10.87
Jul 0.30 0.26 0.32 17.57
Aug 0.31 0.28 0.34 17.90
Sep 0.33 0.30 0.34 13.73
Oct 0.37 0.34 0.38 10.63
Nov 0.36 0.34 0.38 11.49
Dec 0.36 0.32 0.39 17.39
Full forecast for 2025

iSpecimen (ISPC) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 0.36 0.32 0.39 17.00
Feb 0.33 0.30 0.34 12.49
Mar 0.30 0.27 0.31 13.52
Apr 0.35 0.33 0.37 12.14
May 0.37 0.34 0.40 15.27
Jun 0.35 0.31 0.38 18.86
Jul 0.39 0.35 0.43 19.47
Aug 0.38 0.36 0.41 12.27
Sep 0.39 0.37 0.43 14.06
Oct 0.37 0.33 0.39 16.13
Nov 0.35 0.33 0.39 15.94
Dec 0.39 0.35 0.43 18.71
Full forecast for 2026

iSpecimen (ISPC) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 0.42 0.40 0.43 8.42
Feb 0.41 0.38 0.45 15.20
Mar 0.42 0.39 0.47 16.36
Apr 0.40 0.38 0.44 13.75
May 0.44 0.42 0.48 11.25
Jun 0.41 0.37 0.46 19.30
Jul 0.44 0.41 0.48 14.60
Aug 0.38 0.37 0.40 7.22
Sep 0.33 0.32 0.36 12.70
Oct 0.33 0.32 0.38 14.33
Nov 0.34 0.33 0.36 7.44
Dec 0.39 0.37 0.44 15.60
Full forecast for 2027

iSpecimen (ISPC) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 0.41 0.37 0.46 19.85
Feb 0.45 0.40 0.48 17.42
Mar 0.50 0.47 0.54 12.42
Apr 0.53 0.47 0.57 17.33
May 0.51 0.46 0.57 19.34
Jun 0.51 0.48 0.56 14.86
Jul 0.51 0.47 0.57 16.22
Aug 0.55 0.49 0.58 15.89
Sep 0.58 0.54 0.63 15.05
Oct 0.49 0.46 0.54 15.31
Nov 0.47 0.45 0.49 8.04
Dec 0.48 0.45 0.51 11.94
Full forecast for 2028

iSpecimen information and performance

iSpecimen Address

450 BEDFORD STREET, SUITE 1010, LEXINGTON, MA, US

Market Capitalization: 2 062 900 $

Market capitalization of the iSpecimen Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ISPC shares in the company outstanding by the market price of one share.

EBITDA: -11 002 286 $

EBITDA of iSpecimen is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -1.23

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: -0.13
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 0.0017

Enterprise Value (EV) /Revenue

EV To EBITDA: 0.313

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 9087500

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector

ImmunoGen, Inc. (IMGN)
Bristol-Myers Squibb Company (BMY)
Galera Therapeutics, Inc. (GRTX)
Emergent BioSolutions Inc. (EBS)
Gritstone bio, Inc. (GRTS)
Cardinal Health, Inc. (CAH)
Illumina, Inc. (ILMN)
Biogen Inc. (BIIB)
ImmunityBio, Inc. (IBRX)
Foghorn Therapeutics Inc. (FHTX)


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.


This website uses cookies to ensure you get the best experience on our website